Newly Expanded Recommendations on Autism Seek to Catch More Kids Who Might Fall Through the Cracks Paul Zabierek December 17, 2019 READ MORE »
Cognoa Selected as Finalist in Fierce Innovation Awards – LifeSciences Edition 2019 Paul Zabierek December 5, 2019 READ MORE »
ASD symptoms in toddlers and preschoolers: An examination of sex differences Paul Zabierek November 20, 2019 READ MORE »
Cognoa to Participate in BTIG DIGITAL HEALTH and EVERCORE ISI HealthCONx Conferences. Paul Zabierek November 14, 2019 READ MORE »
Digital Therapeutics in Pediatric Behavioral Health — A unique opportunity to improve the standard of care and lifelong outcomes. Paul Zabierek October 28, 2019 READ MORE »
Cognoa Launches Pivotal Study of the First Digital Diagnostic for Autism. Paul Zabierek October 24, 2019 READ MORE »
What are the challenges and opportunities of running clinical trials of digital therapeutics? Paul Zabierek September 26, 2019 READ MORE »
Cognoa and EVERSANA™ announce partnership to advance the commercialization standard for prescription digital medicines. Paul Zabierek September 10, 2019 READ MORE »
Newly Expanded Recommendations on Autism Seek to Catch More Kids Who Might Fall Through the Cracks Paul Zabierek December 17, 2019 READ MORE »
Cognoa Selected as Finalist in Fierce Innovation Awards – LifeSciences Edition 2019 Paul Zabierek December 5, 2019 READ MORE »
ASD symptoms in toddlers and preschoolers: An examination of sex differences Paul Zabierek November 20, 2019 READ MORE »
Cognoa to Participate in BTIG DIGITAL HEALTH and EVERCORE ISI HealthCONx Conferences. Paul Zabierek November 14, 2019 READ MORE »
Digital Therapeutics in Pediatric Behavioral Health — A unique opportunity to improve the standard of care and lifelong outcomes. Paul Zabierek October 28, 2019 READ MORE »
Cognoa Launches Pivotal Study of the First Digital Diagnostic for Autism. Paul Zabierek October 24, 2019 READ MORE »
What are the challenges and opportunities of running clinical trials of digital therapeutics? Paul Zabierek September 26, 2019 READ MORE »
Cognoa and EVERSANA™ announce partnership to advance the commercialization standard for prescription digital medicines. Paul Zabierek September 10, 2019 READ MORE »